Clinigen

In today's data-driven healthcare landscape, real-world data (RWD) is an invaluable asset for informing clinical decisions. In his latest article, Hasan Kobat, Clinigen’s Business Development Lead in Real-World Data, dives into the potential of RWD to bridge the gap between clinical trials and real-world practice, enhance healthcare outcomes through Managed Access Programs (MAPs), and ultimately support the development of personalised and effective treatments.   Read it here – https://lnkd.in/gb2dNKf3   #RWD #ClinicalTrials #MAPs #DrugDevelopment #RealWorldEvidence

We're excited to announce we will be attending the European Hematology Association (EHA) 2024 Congress in Madrid, Spain. Join our commercial and medical teams at booth H19 from 13th – 16th June. They are eager to connect and explore how our broad services can support seamless access and reliable supply for your product, at every stage of its lifecycle. #Clinigen #EHA2024 #Hematology #Partnerships #Innovation #PatientFocus

Clinigen is proud to announce the acquisition of Ascenian , a leading US and Germany-based market access consultancy. This strategic move strengthens our position as the premier global provider of high-value services to the pharmaceutical and biotechnology sectors. Together, we'll make a real difference in the lives of patients worldwide. https://lnkd.in/gK2p9vgq

Collecting Real World Data within a Managed Access Program can build a comprehensive understanding of a medicine. If you are keen to learn more about Clinigen’s Real World Data service, reach out to Hasan Kobat, who will be attending this year’s ASCO Annual Meeting in Chicago, IL. Book a meeting with him here – https://lnkd.in/eEwYNrfY #ASCO2024 #RWD #Clinigen #ExpandedAccess #CancerTreatment #PatientAccess 

The Clinigen Commercial team are looking forward to meeting you at BIO International 2024 in San Diego from 3rd to 6th June! We're passionate about partnering with biopharmaceutical companies to bring life-changing treatments to patients worldwide.   Jules Shale, PhD, Pete Solman and David Wojciechowski will be in attendance, to book a meeting with them click here https://lnkd.in/eEwYNrfY.   Kuba Chiagorom from our Clinical Supplies Management team and Rob Fox, VP Corporate Development, will also be there, don’t hesitate to reach out.   #BIO2024 #Clinigen #Inlicensing #Commercial #Biopharma #DrugDevelopment #clinicaltrialsupplies

Join Clinigen at BIO International 2024 from 3rd to 6th June, in San Diego, USA!   Jules Shale, PhD, Pete Solman and David Wojciechowski from our Commercial team are looking forward to discuss how Clinigen’s comprehensive range of services can support access and supply throughout your product lifecycle.   Kuba Chiagorom from our Clinical Supply and Management (CSM) team will also be there, ready to hear about your clinical supply needs.   Why not book a meeting with us here – https://lnkd.in/eEwYNrfY   #BIO2024 #Clinigen #Commercial #Inlicensing #Biopharma #Unlicensed #DrugDevelopment #clinicaltrialsupply

We're excited to attend the American Society of Clinical Oncology (ASCO) Annual Meeting 2024 from May 31 to June 4, in Chicago!   Clinigen bridges the gap between groundbreaking treatments and patients with unmet medical need. We can help you secure access to your therapy for those patients when clinical trials are not available.   Book a meeting with Neil Watson, Nicky Edwards, Caroline O’Toole and Hasan Kobat to learn how Clinigen's expertise can help you navigate the intricacies of Managed Access Program implementation – https://lnkd.in/eEwYNrfY   #ASCO24 #Clinigen #ExpandedAccess #CancerTreatment #PatientAccess 

Did you know there are over 7,000 rare diseases impacting 300 million people globally? Clinigen Global Patient Engagement Lead, Dr Lorna Pender discusses the importance of raising awareness and improving access to treatments in a recent interview with Pharmaceutical Market Europe. Read more about her insights and our commitment to the rare disease community: https://bit.ly/44zOYYa #ClinigenCares #RareDisease #PatientAdvocacy

We're delighted to be Bronze Sponsor at the upcoming #SIOPEurope2024, set to take place from 13 to 17 May in Milan, Italy!   Join us at booth # 7 and meet members of our medical and commercial teams. Alternatively, get in touch and schedule some time to meet https://lnkd.in/eEwYNrfY.   And mark your calendars for 10:00am on 14th May for our sponsored symposium: "Native Erwinia Chrysanthemi Asparaginase : How to continue a long and successful story?". #Commercialisation #Medical #SIOP #Milan

Join Neil Watson, Jules Shale, PhD and Melanie-Rose Brown at World Orphan Drug Congress USA next week in Boston, MA!   The World Orphan Drug Congress is a premier event bringing together the entire orphan drug community – pharmaceutical and biotech companies, regulators, patient advocacy groups, payers, investors, and solution providers.   Please get in touch and find some time to meet! https://lnkd.in/eEwYNrfY   #ManagedAccess #ExpandedAccess #EarlyAccess #Commercialisation #Regulatory #WorldOrphanUSA #RareDisease #OrphanDrug